Gilberto O. Lobaton

Gilberto O. Lobaton

Auto-generated profile, based on publicly available information

Gilberto O. Lobaton

Department of Orthopedics, University of Miami Miller School of Medicine, 1321 NW 14th St. Suite 306, Miami, FL, 33125, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in Clinical Science
Verified
Journal Article
Closed access
PDF file
SKSeungbum Kim
Seungbum Kim
RGRuby Goel
Ruby Goel
AKAshok Kumar
Ashok Kumar
YQYanfei Qi
Yanfei Qi
GLGil Lobaton
Gil Lobaton
MRMohan K. Raizada
Mohan K. Raizada
Recent evidence indicates a link between gut pathology and microbiome with hypertension (HTN) in animal models. However, whether this association exists in humans is unknown. Thus, our objectives in the present study were to test the hypotheses that high blood pressure (BP) patients have distinct gut microbiomes and that gut–epithelial barrier function markers and microbiome composition could predict systolic BP (SBP). Fecal samples, analyzed by shotgun metagenomics, displayed taxonomic and functional changes, including altered butyrate production between patients with high BP and reference subjects. Significant increases in plasma of intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), and augmented gut-targetting proinflammatory T helper 17 (Th17) cells in high BP patients demonstrated increased intestinal inflammation and permeability. Zonulin, a gut epithelial tight junction protein regulator, was markedly elevated, further supporting gut barrier dysfunction in high BP. Zonulin strongly correlated with SBP (R2 = 0.5301, P<0.0001). Two models predicting SBP were built using stepwise linear regression analysis of microbiome data and circulating markers of gut health, and validated in a separate cohort by prediction of SBP from zonulin in plasma (R2 = 0.4608, P<0.0001). The mouse model of HTN, chronic angiotensin II (Ang II) infusion, was used to confirm the effects of butyrate and gut barrier function on the cardiovascular system and BP. These results support our conclusion that intestinal barrier dysfunction and microbiome function are linked to HTN in humans. They suggest that manipulation of gut microbiome and its barrier functions could be the new therapeutic and diagnostic avenues for HTN.

20 January 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MSMonica M. Santisteban
Monica M. Santisteban
YQYanfei Qi
Yanfei Qi
JZJasenka Zubcevic
Jasenka Zubcevic
SKSeungbum Kim
Seungbum Kim
TYTao Yang
Tao Yang
MRMohan K. Raizada
Mohan K. Raizada
Rationale:: Sympathetic nervous system control of inflammation plays a central role in hypertension. The gut receives significant sympathetic innervation, is densely populated with a diverse microbial ecosystem, and contains immune cells that greatly impact overall inflammatory homeostasis. Despite this uniqueness, little is known about the involvement of the gut in hypertension. Objective:: Test the hypothesis that increased sympathetic drive to the gut is associated with increased gut wall permeability, increased inflammatory status, and microbial dysbiosis and that these gut pathological changes are linked to hypertension. Methods and Results:: Gut epithelial integrity and wall pathology were examined in spontaneously hypertensive rat and chronic angiotensin II infusion rat models. The increase in blood pressure in spontaneously hypertensive rat was associated with gut pathology that included increased intestinal permeability and decreased tight junction proteins. These changes in gut pathology in hypertension were associated with alterations in microbial communities relevant in blood pressure control. We also observed enhanced gut–neuronal communication in hypertension originating from paraventricular nucleus of the hypothalamus and presenting as increased sympathetic drive to the gut. Finally, angiotensin-converting enzyme inhibition (captopril) normalized blood pressure and was associated with reversal of gut pathology. Conclusions:: A dysfunctional sympathetic–gut communication is associated with gut pathology, dysbiosis, and inflammation and plays a key role in hypertension. Thus, targeting of gut microbiota by innovative probiotics, antibiotics, and fecal transplant, in combination with the current pharmacotherapy, may be a novel strategy for hypertension treatment.

1 August 2018 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
AOAline C. Oliveira
Aline C. Oliveira
RSRavindra K. Sharma
Ravindra K. Sharma
VAVictor Aquino
Victor Aquino
GLGilberto Lobaton
Gilberto Lobaton
ABAndrew J. Bryant
Andrew J. Bryant
MRMohan K. Raizada
Mohan K. Raizada

1 January 2021 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
GLGilberto O Lobaton
Gilberto O Lobaton
YCY Julia Chen
Y Julia Chen
EJEric Jelin
Eric Jelin
AGAlejandro V Garcia
Alejandro V Garcia
Congenital diaphragmatic hernias rarely present after 2 months of age and are typically diagnosed in the perinatal period. Moderate to severe diaphragmatic hernias present with respiratory symptoms, while late-onset hernias have a more varied presentation, depending on the age and content of the hernia. Very rarely, such hernias are found on incidental imaging, in which surgical repair is frequently recommended. A young girl with Loeys-Dietz syndrome and prior abdominal surgeries presents with 1-year history of increasingly severe, intermittent, abdominal and left shoulder pain. Prior imaging incidentally revealed a left diaphragmatic hernia with omentum protruding into the thoracic cavity. This was managed expectantly due to her other medical and surgical issues. Serial imaging revealed that the herniated omentum was increasing in size and symptoms began to develop. An uncomplicated primary thoracoscopic repair was performed. We report the first case of a congenital diaphragmatic hernia in a patient with Loeys-Dietz syndrome.

1 January 2019 in JBJS Case Connector
Verified
Journal Article
Closed access
GLGilberto O. Lobaton
Gilberto O. Lobaton
MMMajd Marrache
Majd Marrache
OPOlivia Petrusky
Olivia Petrusky
DCDavid B. Cohen
David B. Cohen
AJAmit Jain
Amit Jain
Case: A 62-year-old man with no comorbidities presented with back and bilateral leg pain and progressive paraplegia that developed over a 1-week period. He had received 2 lumbar epidural steroid injections (LESIs) for lumbar stenosis 39 and 25 days before presentation. Workup revealed osteomyelitis of L4 and L5 with epidural abscesses. He ultimately underwent all-posterior L4 and L5 corpectomy with reconstruction and L1-pelvis arthrodesis, followed by 8 weeks of intravenous antibiotics. His weakness improved, but neurological deficits persisted. Conclusions: This case illustrates a catastrophic complication after LESI, resulting in permanent neurological injury in a patient with no apparent risk factors.

13 June 2024 in Journal of Orthopaedics
Verified
Journal Article
Closed access
GHGriffin Harris
Griffin Harris
NPNikhil Patel
Nikhil Patel
GLGilberto O. Lobaton
Gilberto O. Lobaton
CCClementina Cabrera
Clementina Cabrera
DQDaniel Quintero
Daniel Quintero
JJJean Jose
Jean Jose